Federated Hermes’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34	Closed	-$4.28K	–	2156
2023 Q1	$4.28K	Sell	34 -6	-15%	-$1.35K	﹤0.01%	1950
2022 Q4	$12.2K	Sell	40 -11	-22%	-$1.62K	﹤0.01%	1847
2022 Q3	$3K	Hold	51	–	–	﹤0.01%	1934
2022 Q2	$3K	Sell	51 -2,120	-98%	-$157K	﹤0.01%	1945
2022 Q1	$248K	Sell	2,171 -1,284	-37%	-$151K	﹤0.01%	1565
2021 Q4	$497K	Buy	3,455 +9	+0.3%	+$1.63K	﹤0.01%	1482
2021 Q3	$755K	Buy	3,446 +10	+0.3%	+$2.12K	﹤0.01%	1380
2021 Q2	$797K	Buy	3,436 +10	+0.3%	+$2.54K	﹤0.01%	1381
2021 Q1	$1.03M	Sell	3,426 -704	-17%	-$252K	﹤0.01%	1361
2020 Q4	$1.55M	Sell	4,130 -869	-17%	-$305K	﹤0.01%	1163
2020 Q3	$1.53M	Sell	4,999 -10	-0.2%	-$3.82K	﹤0.01%	1081
2020 Q2	$1.88M	Buy	5,009 +563	+13%	+$159K	﹤0.01%	1014
2020 Q1	$1.01M	Buy	4,446 +3,068	+223%	+$1.17M	﹤0.01%	1135
2019 Q4	$729K	Buy	+1,378	New	+$746K	﹤0.01%	1359
2018 Q1	–	Sell	-9	Closed	-$16K	–	2178
2017 Q4	$16K	Buy	+9	New	+$11.9K	﹤0.01%	1805
2015 Q3	–	Sell	-1	Closed	-$1K	–	2002
2015 Q2	$1K	Buy	+1	New	+$827	﹤0.01%	1899